|
| [8] | A. Queck, H. Bode, F. E. Uschner, M. J. Brol, C. Graf, M. Schulz, C. Jansen, M. Praktiknjo, R. Schierwagen, S. Klein, C. Trautwein, H. E. Wasmuth, M. Berres, J. Trebicka, J. Lehmann,
"Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis", Frontiers in immunology, vol. 11, 2020, pp. 354.
|
|
| [7] | D. Heinrichs, E. F. Brandt, P. Fischer, J. Köhncke, T. Wirtz, N. Guldiken, S. Djudjaj, P. Boor, D. C. Kroy, R. Weiskirchen, R. Bucala, H. E. Wasmuth, P. Strnad, C. Trautwein, J. Bernhagen, M. Berres,
"Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations", Cells, vol. 10, no. 2, 2021, pp. 252.
|
| [6] | A. Queck, F. E. Uschner, P. G. Ferstl, M. Schulz, M. J. Brol, M. Praktiknjo, R. Schierwagen, S. Klein, C. P. Strassburg, C. Meyer, C. Jansen, M. Berres, J. Trebicka,
"Role of circulating angiogenin levels in portal hypertension and TIPS", PLOS ONE, vol. 16, no. 8, 2021, pp. e0256473.
|
| [5] | T. Wirtz, P. A. Reuken, C. Jansen, P. Fischer, I. Bergmann, C. Backhaus, C. Emontzpohl, J. Reißing, E. F. Brandt, M. T. Koenen, K. M. Schneider, R. Schierwagen, M. J. Brol, J. Chang, H. W. Zimmermann, N. Köse-Vogel, T. Eggermann, I. Kurth, C. Stoppe, R. Bucala, J. Bernhagen, M. Praktiknjo, A. Stallmach, C. Trautwein, J. Trebicka, T. Bruns, M. Berres,
"Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis", JHEP reports, vol. 3, no. 2, 2021, pp. 100221.
|
| [4] | T. Wirtz, A. Saal, I. Bergmann, P. Fischer, D. Heinrichs, E. F. Brandt, M. T. Koenen, S. Djudjaj, K. M. Schneider, P. Boor, R. Bucala, R. Weiskirchen, J. Bernhagen, C. Trautwein, M. Berres,
"Macrophage migration inhibitory factor exerts pro‐proliferative and anti‐apoptotic effects via CD74 in murine hepatocellular carcinoma", British journal of pharmacology, vol. 178, no. 22, 2021, pp. 4452–4467.
|
|
| [3] | J. F. Brozat, E. F. Brandt, M. Stark, P. Fischer, T. Wirtz, A. Flaßhove, A. N. Rodenhausen, T. Vajen, A. C. A. Heinzmann, S. M. Schmitz, S. Abu Jhaisha, A. A. J. Röth, R. R. Koenen, H. Sahin, C. Trautwein, M. Berres,
"JAM‐A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence", Liver international, vol. 42, no. 5, 2022, pp. 1185–1203.
|
|
| [2] | J. Soppert, E. F. Brandt, N. M. Heussen, E. Barzakova, L. M. Blank, L. Küpfer, M. W. Hornef, J. Trebicka, J. Jankowski, M. Berres, H. Noels,
"Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease: a systematic review and meta-analysis", Clinical Gastroenterology and Hepatology, vol. 21, no. 11, 2023, pp. 2746–2758.
|
| [1] | S. Torres, C. Ortiz, N. Bachtler, W. Gu, L. D. Grünewald, N. Kraus, R. Schierwagen, C. Hieber, C. Meier, O. Tyc, M. Joseph Brol, F. E. Uschner, B. Nijmeijer, C. Welsch, M. Berres, C. Garcia-Ruiz, J. C. Fernandez-Checa, C. Trautwein, T. J. Vogl, S. Zeuzem, J. Trebicka, S. Klein,
"Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis", Hepatology, vol. 77, no. 4, 2023, pp. 1228–1240.
|